Fabry Disease Research Highlights at WORLDSymposium 2023
Fabry Disease Research Highlights at WORLDSymposium 2023 is organized by American Academy of CME, Inc., CheckRare .
Start date: April 30, 2023
End date: April 30, 2024
Activity Description:
This 30-minute CME-accredited program highlights the latest clinical research about Fabry disease, a rare X-linked lysosomal disorder that results in the cellular buildup of globotriaosylceramide. Characteristic features of Fabry disease include acroparesthesias, angiokeratomas, hypohidrosis, corneal opacity, gastrointestinal problems, tinnitus, and hearing loss. Fabry disease also involves potentially life-threatening complications such as progressive kidney damage, heart attack, and stroke. This CME program, hosted by Staci Kallish, DO, Associate Professor of Clinical Medicine at the University of Pennsylvania Health System Penn Medicine, provides an overview of the latest clinical research presented at WORLDSymposium 2023 focused on Fabry disease.
Learning Objective:
After participating in the activity, learners should be better able to:
• Describe the latest research being presented to better manage individuals with Fabry disease and its clinical relevance.
Additional details will be posted as soon as information is available.